医学
化学免疫疗法
麦克内马尔试验
回顾性队列研究
放射科
完全响应
放射治疗
新辅助治疗
病态的
结直肠癌
置信区间
诊断准确性
磁共振成像
核医学
试验预测值
外科
肿瘤科
癌症
实体瘤疗效评价标准
一致性
内科学
超声波
活检
放化疗
作者
Zhihao Hu,Min Chen,Hua Li,Haode Shen,Kun Xu,Qin Pi,Zhaoyang Zhong,Weidong Tong,Fan Li
标识
DOI:10.1080/14796694.2026.2760122
摘要
BACKGROUND: Accurate imaging-based response assessment is essential for proficient mismatch repair (pMMR) locally advanced rectal cancer (LARC). This study aimed to evaluate the diagnostic performance of MRI, endorectal ultrasound (ERUS) and 18F-FAPI PET/MRI for identifying pathological complete response (pCR) after neoadjuvant short-course radiotherapy (SCRT) followed by chemoimmunotherapy. METHODS: This single-center retrospective study included 143 patients. Diagnostic performance was assessed using sensitivity, specificity, and accuracy with 95% confidence intervals. Cohen's κ assessed agreement between imaging-defined complete response (iCR) and pCR. Paired comparisons used Cochran's Q and Holm-adjusted exact McNemar tests. RESULTS: = 25) achieved sensitivity, specificity, and accuracy of 4.76%, 98.18%, and 48.31%; 30.95%, 87.18%, and 58.02%; and 60.0%, 100.0%, and 84.0%, respectively. PET/MRI-assessed imaging complete response showed substantial agreement with pCR (κ = 0.643). CONCLUSION: Neoadjuvant SCRT followed by chemoimmunotherapy achieved high pCR rates in pMMR LARC. Conventional MRI and ERUS showed limited sensitivity despite relatively high specificity. 18F-FAPI PET/MRI showed potential diagnostic utility in a small subgroup, but its moderate sensitivity and limited sample size warrant further validation. These findings highlight the limitations of imaging alone and the need for comprehensive response assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI